Guidant DES Strategy Will Be Guided By Bare-Metal Stent Experience

Guidant will support its initial drug-eluting stent PMA submission with the 975-patient FUTURE IV randomized, pivotal trial, slated to begin at up to 70 sites in the second quarter of 2004